ConductScience.org, home

Trial · NCT06664801

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

NCT06664801, Phase 2, Completed, Merck Sharp & Dohme LLC

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024). Trials, record NCT06664801. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06664801

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)
NCT number
NCT06664801
Status
Completed
Phases
Phase 2
Enrollment
164 participants, actual
Lead sponsor
Merck Sharp & Dohme LLC
Conditions
Pulmonary Arterial Hypertension
Interventions
Sotatercept, Background PAH Therapy
First posted
2024-10-30
Last updated
2025-12-05

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySteady-State Average Serum Concentrations of Sotatercept (Cavg)Predose and at designated time points post-dose (up to 24 weeks)Steady-state Cavg of sotatercept will be reported.
PrimaryNumber of Participants Who Experience One or More Adverse Events (AEs)Up to 37 weeksAn AE is a health problem that happens or worsens during a study. Number of participants who experience an AE will be reported.
PrimaryNumber of Participants who Discontinue Study Treatment due to an Adverse EventUp to 21 weeksAn AE is a health problem that happens or worsens during a study. Number of participants who discontinue study treatment will be reported.
SecondaryInitial Dose Average Serum Concentrations of Sotatercept (Cavg)Predose and at designated time points post-dose (up to 3 weeks)Initial dose Cavg of sotatercept will be reported.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06664801

GET https://conductscience.org/api/trials/v1/NCT06664801/registered